AbbVie
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade AbbVie 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
CEORobert A. Michael
CEORobert A. Michael
Employees55,000
Employees55,000
HeadquartersNorth Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded2011
Founded2011
Employees55,000
Employees55,000
ABBV Key Statistics
Market cap328.61B
Market cap328.61B
Price-Earnings ratio79.09
Price-Earnings ratio79.09
Dividend yield3.44%
Dividend yield3.44%
Average volume4.48M
Average volume4.48M
High today$187.12
High today$187.12
Low today$183.70
Low today$183.70
Open price$185.58
Open price$185.58
Volume2.21M
Volume2.21M
52 Week high$218.66
52 Week high$218.66
52 Week low$163.52
52 Week low$163.52
ABBV News
Simply Wall St 1h
AbbVie Announces Positive Phase 3 Results for Migraine Drug Atogepantrecently announced positive results from its Phase 3 TEMPLE study, marking significant progress in migraine treatment. Over the last month, AbbVie’s stock price...
Analyst ratings
60%
of 30 ratingsBuy
60%
Hold
40%
Sell
0%
People also own
Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.